Covid-19 vaccine by August this year. Biological E Ltd is done with phase 1 and phase 2 trials. Now, they are ready for phase 3 trails."Phase 1, phase 2 trials of Indian vaccine of Biological E have finished and they'll soon go into phase 3.
This is a very significant development as they have a capacity of 7 crore/ 70 million vaccines per month," NITI Aayog member Dr VK Paul said today.Biological E Ltd will manufacture 1 billion doses of Covid-19 vaccines including the one developed by Johnson & Johnson under the Quad Vaccine Partnership, a White House press note had earlier said."The United States, through the DFC (Development Finance Corporation), will work with Biological E Ltd, to finance increased capacity to support Biological E's.